Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding
Others
Ratios

Syndax Pharmaceuticals (SNDX) Operating Expenses (2016 - 2020)

Historic Operating Expenses for Syndax Pharmaceuticals (SNDX) over the last 6 years, with Q4 2020 value amounting to $20.2 million.

  • Syndax Pharmaceuticals' Operating Expenses rose 3877.27% to $20.2 million in Q4 2020 from the same period last year, while for Sep 2021 it was $20.2 million, marking a year-over-year decrease of 6991.9%. This contributed to the annual value of $363.4 million for FY2024, which is 5801.07% up from last year.
  • Syndax Pharmaceuticals' Operating Expenses amounted to $20.2 million in Q4 2020, which was up 3877.27% from $20.2 million recorded in Q3 2020.
  • Syndax Pharmaceuticals' Operating Expenses' 5-year high stood at $20.7 million during Q4 2017, with a 5-year trough of $8.9 million in Q2 2016.
  • For the 5-year period, Syndax Pharmaceuticals' Operating Expenses averaged around $15.9 million, with its median value being $15.6 million (2016).
  • Per our database at Business Quant, Syndax Pharmaceuticals' Operating Expenses skyrocketed by 15219.86% in 2016 and then tumbled by 2601.33% in 2019.
  • Quarter analysis of 5 years shows Syndax Pharmaceuticals' Operating Expenses stood at $11.4 million in 2016, then soared by 80.69% to $20.7 million in 2017, then fell by 4.69% to $19.7 million in 2018, then fell by 26.01% to $14.6 million in 2019, then surged by 38.77% to $20.2 million in 2020.
  • Its last three reported values are $20.2 million in Q4 2020, $20.2 million for Q3 2020, and $17.0 million during Q2 2020.